Caxton Associates (New York)’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,544
| Closed | -$380K | – | 483 |
|
|
2024
Q3 | $380K | Sell |
8,544
-28,909
| -77% | -$1.28M | 0.01% | 403 |
|
|
2024
Q2 | $1.61M | Buy |
37,453
+264
| +0.7% | +$11.4K | 0.06% | 182 |
|
|
2024
Q1 | $1.09M | Buy |
+37,189
| New | +$1.09M | 0.06% | 205 |
|
|
2023
Q1 | – | Sell |
-13,959
| Closed | -$392K | – | 481 |
|
|
2022
Q4 | $392K | Sell |
13,959
-9,501
| -40% | -$267K | 0.03% | 271 |
|
|
2022
Q3 | $663K | Buy |
23,460
+2,232
| +11% | +$63.1K | 0.09% | 170 |
|
|
2022
Q2 | $471K | Buy |
+21,228
| New | +$471K | 0.05% | 273 |
|